Immediate Procedures Segment to Lead Market During 2021–2028
According to our new research study on “PCR for respiratory infection diagnostics market” Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Product Type, Infection Type, End User,” the market is expected to reach US$ 8279.32 million by 2028 from US$ 4,146.02 million in 2021; it is estimated to grow at a CAGR of 10.4% from 2021 to 2028. The report highlights trends prevailing in the market and factors driving its growth. The market growth is mainly attributed to the factors such as the increasing Burden of Chronic Respiratory Diseases (CRDs), growing developments in PCR testing, are widely enhancing the performance of medical devices. However, use of PCR testing for various respiratory infection diagnostics and developments in PCR technology being used to derive them. The availability of alternative assays hinders the market growth.
The PCR for respiratory infection diagnostics market is segmented real time PCR (qPCR), multiplex PCR, traditional PCR, digital PCR, reverse transcriptase PCR (RT-PCR) and others. The real time PCR held the largest share in 2021, also the same segment is anticipated to register the highest CAGR in the market during the coming years. Real Time PCR Real-time reverse transcription polymerase chain reaction (RT–PCR) is a nuclear-based approach for identifying the presence of specific genetic material in any disease, including viruses. Originally, radioactive isotope markers are used to detect specific genetic elements, but later improvement has resulted in the application of specialized markers, most often fluorescent dyes, to replace isotopic labelling.
Thermo Fisher Scientific Inc.; Bio-Rad Laboratories Inc.; Abbott; F. Hoffmann-La Roche Ltd; Hologic, Inc.; Seegene Inc.; AusDiagnostics; BD; bioMérieux SA; and Qiagen are among the leading companies operating in the PCR for respiratory infection diagnostics market.
PCR for Respiratory Infection Diagnostics Market by Region, 2020 (%) PCR For Respiratory Infection Diagnostic Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Real-Time PCR (qPCR), Multiplex PCR, Traditional PCR, Digital PCR, Reverse-Transcriptase(RT-PCR),and Others), Product Type (Reagents and kits, Instruments, and Others), Infection Type (Virus Infections, Bacteria Infections, and Fungal and other pathogens), and End Users (Hospitals, Physician Clinics, Clinical Laboratories, Academic and Research Institutions, Biotech and Pharma Companies, and Others) and Geography
PCR For Respiratory Infection Diagnostic Market Analysis 2028
Download Free Sample
The report segments the pcr for respiratory infection diagnostics market as follows:
By Type
- Real-Time PCR (qPCR)
- Multiplex PCR
- Traditional PCR
- Digital PCR
- Reverse-Transcriptase (RT-PCR)
- Others
By Product Type
- Reagents and Kits
- Instruments
- Others
By Infection Type
- Bacterial Infections
- Bordetella
- Streptococcus Pneumoniae
- Staphylococcus Aureus
- Haemophilus Influenzae
- Moraxella Catarrhalis
- Mycoplasma Pneumoniae
- Chlamydophila Pneumoniae
- Legionella
- Others
- Viral Infections
- Rhinoviruses
- Influenza Virus
- Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus
- Respiratory Syncytial Virus (RSV)
- Adenovirus
- Enterovirus
- Parainfluenza
- Human Metapneumovirus (hMPV)
- Others
- Fungal and Other Pathogens
By End User
- Hospitals
- Physician Clinics
- Clinical Laboratories
- Academic and Research Institutions
- Biotech and Pharma Companies
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- UK
- Spain
- Netherlands
- Norway
- Italy
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- Japan
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East and Africa (MEA)
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East and Africa
- South and Central America (SCAM)
- Brazil
- Argentina
- Rest of South and Central America
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com